Evaluation of protective efficacy of three novel H3N2 canine influenza vaccines.

about

Evaluation of protective efficacy of three novel H3N2 canine influenza vaccines.

Item

http://www.wikidata.org/entity/Q47117776

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Evaluation of protective efficacy of three novel H3N2 canine influenza vaccines.

@en

Evaluation of protective efficacy of three novel H3N2 canine influenza vaccines.

@nl

type

Item

label

Evaluation of protective efficacy of three novel H3N2 canine influenza vaccines.

@en

Evaluation of protective efficacy of three novel H3N2 canine influenza vaccines.

@nl

prefLabel

Evaluation of protective efficacy of three novel H3N2 canine influenza vaccines.

@en

Evaluation of protective efficacy of three novel H3N2 canine influenza vaccines.

@nl

P1476

Evaluation of protective efficacy of three novel H3N2 canine influenza vaccines.

@en

P2093

Kun Jia

http://www.w3.org/2001/XMLSchema#string

Lingshuang Sun

http://www.w3.org/2001/XMLSchema#string

Liqing Tu

http://www.w3.org/2001/XMLSchema#string

Lutao Li

http://www.w3.org/2001/XMLSchema#string

Pei Zhou

http://www.w3.org/2001/XMLSchema#string

Renjun Hu

http://www.w3.org/2001/XMLSchema#string

Shoujun Li

http://www.w3.org/2001/XMLSchema#string

Xiuzhen Li

http://www.w3.org/2001/XMLSchema#string

Ziguo Yuan

http://www.w3.org/2001/XMLSchema#string

P2860

Seasonal inactivated influenza virus vaccines

Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin.

Long-term immunogenicity of an inactivated split-virion 2009 pandemic influenza A H1N1 virus vaccine with or without aluminum adjuvant in mice

A cell-based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models.

A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.

An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses.

Virulence of a novel reassortant canine H3N2 influenza virus in ferret, dog and mouse models.

Canine influenza.

An MDCK cell culture-derived formalin-inactivated influenza virus whole-virion vaccine from an influenza virus library confers cross-protective immunity by intranasal administration in mice.

The development of live attenuated cold-adapted influenza virus vaccine for humans.

P304

98084-98093

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.21104

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29228675

http://www.w3.org/2001/XMLSchema#string

P932

5716715

http://www.w3.org/2001/XMLSchema#string